Welcome to our dedicated page for Gevo SEC filings (Ticker: GEVO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Gevo, Inc. (GEVO) SEC filings page brings together the company’s regulatory disclosures, including Form 8-K current reports, that describe material events affecting this renewable fuels, chemicals, and carbon management business. These filings provide detail on topics such as executive leadership changes, amendments to corporate bylaws, project financing, carbon credit sales agreements, and tax credit transfer arrangements tied to ethanol and renewable natural gas production.
Through its filings, Gevo outlines how it monetizes Section 45Z Clean Fuel Production Credits generated from ethanol volumes at its North Dakota facility, including tax credit transfer agreements with financial institutions and banks. Other 8-Ks describe bond financing agreements used to refinance revenue bonds for its dairy-based renewable natural gas project in Iowa, as well as carbon dioxide removal sales agreements with counterparties like Biorecro North America, LLC for credits associated with its carbon capture and sequestration facilities.
Investors can use annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) to review segment information related to ethanol, renewable natural gas, and carbon activities, along with risk factors and management’s discussion and analysis. Current reports on Form 8-K capture governance developments such as the appointment of a new president who is expected to become chief executive officer, the adoption of third amended and restated bylaws, and other corporate actions.
On Stock Titan, these filings are complemented by AI-powered summaries that highlight key points from lengthy documents, helping readers understand complex items like tax credit transfer structures, carbon dioxide removal contracts, and project financing terms. Real-time updates from EDGAR ensure that new GEVO filings, including Forms 10-K, 10-Q, and 4 (insider transaction reports), are accessible as they are posted. This combination of primary documents and AI explanations can save time for users who want to track how Gevo structures its low-carbon fuel, RNG, and carbon credit businesses through formal SEC disclosures.
Gevo, Inc. (GEVO) insider Form 4: Paul D. Bloom, Chief Business Officer, reported sales of 2,092 shares of Gevo common stock on 09/04/2025 at a weighted average price of $1.6298 per share (individual trades ranged $1.61–$1.64). The sales were executed pursuant to a 10b5-1 trading plan adopted November 21, 2024, and were used to satisfy tax-withholding obligations upon vesting of a restricted stock award. The report also notes the reporting person holds 998,591 shares directly and 22,039.17 shares indirectly through the company 401(k) plan, with 8.4 401(k) shares disposed between August 5, 2025 and September 4, 2025 to cover administrative fees.
Gevo, Inc. insider filing (Form 4) shows President & COO Ryan Christopher Michael sold 1,683 shares of Gevo common stock on 09/04/2025 at a weighted average price of $1.6295 per share to cover tax withholding on vesting restricted stock awards. The sales were made under a 10b5-1 trading plan adopted November 26, 2024. After the reported transactions the reporting person beneficially owned 1,631,938 shares directly and held an indirect position of 22,016.68 shares through a 401(k) plan. The filing also notes the disposition of 8.35 shares from the 401(k) between 08/05/2025 and 09/04/2025 to cover administrative fees.
Patrick R. Gruber, Gevo, Inc. CEO and Director, reported insider share disposals on Form 4 dated 09/05/2025 reflecting transactions on 09/04/2025. The filing shows 1,642 shares sold at a weighted average price of $1.6295 per share under a 10b5-1 plan to cover tax withholding upon vesting of a restricted stock award. After the reported sale, Mr. Gruber beneficially owns 3,845,462 shares directly.
The filing also notes 22,017.45 shares held indirectly through a 401(k) plan and a separate disposal of 8.51 shares under the 401(k) between August 5, 2025 and September 4, 2025 to cover administrative fees. The 10b5-1 plan was adopted on November 14, 2024.
Insider sale notice for Gevo, Inc. (GEVO): The filing reports a proposed sale of 1,731 shares of common stock through Stifel Nicolaus on or about 09/04/2025 with an aggregate market value of $2,821. Those shares were acquired as restricted stock units on 09/03/2025 and payment was in cash. The filer previously sold 57,651 shares on 08/20/2025 for $93,942 and 5,738 shares on 08/05/2025 for $7,061. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.
Form 144 filed for Gevo, Inc. (GEVO) reporting a proposed sale of 1,683 shares of Common Stock through Stifel Nicolaus & Company, with an aggregate market value of $2,742.00 and an approximate sale date of 09/04/2025. The securities were acquired as Restricted Stock Units on 09/03/2025 from the issuer and the filing states payment on 09/04/2025 in cash. The filing lists total shares outstanding of 239,562,995 for the issuer. The filer also disclosed two prior sales by Christopher Ryan in August 2025 totaling 86,463 shares for gross proceeds of $107,381.00 (42,499 shares on 08/05/2025 for $52,299.00 and 43,964 shares on 08/01/2025 for $55,082.00). The notice includes the standard attestation that the seller is not aware of undisclosed material adverse information.
Gevo, Inc. Form 144 notice: An affiliated person proposes to sell 1,642 shares of Gevo common stock through Stifel Nicolaus on 09/04/2025 with an aggregate market value of $2,183.00. The securities were acquired as Restricted Stock Units on 09/03/2025 from the issuer and payment is listed as cash on 09/04/2025. The filer discloses two prior sales by the same person during August 2025: 116,060 shares on 08/05/2025 for $142,823.00 and 120,304 shares on 08/01/2025 for $150,728.88. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Gevo, Inc. Form 144 summary: An insider filing discloses a proposed sale of 1,530 shares of Gevo common stock through Stifel Nicolaus & Company Inc. with an aggregate market value of $2,493.00, and an approximate sale date of 09/04/2025. The filing reports the securities were acquired as restricted stock units on 09/03/2025 and payment is indicated as cash on 09/04/2025. The filing lists total shares outstanding as 239,562,995. The filer previously sold 12,370 shares on 08/05/2025 (gross proceeds $15,223.00) and 11,694 shares on 08/01/2025 (gross proceeds $14,651.00).
Gevo, Inc. Form 144 notice reports proposed sales of restricted stock converted to common stock and recent reported disposals by an insider. The filing shows 2,092 shares of Common Stock listed for proposed sale through Stifel Nicolaus on 09/04/2025 on Nasdaq with an aggregate market value of $3,411.00. The shares were acquired as Restricted Stock Units on 09/03/2025 and payment is listed as cash on 09/04/2025. The filing also discloses four prior sales by Paul Bloom in August 2025 totaling 75,228 shares for gross proceeds of $93,148.00. Several standard issuer and filer identification fields in the form are not populated in the provided content.
Agiri Oluwagbemileke Yusuf, CFO of Gevo, Inc. (GEVO), reported the sale of 57,651 shares of Gevo common stock on 08/20/2025 at a weighted average price of $1.6295 per share. After the reported disposition, the filing shows the reporting person beneficially owns 277,835 shares directly and holds an additional 18,977.57 shares indirectly through a 401(k) plan. The footnote clarifies the sale occurred in multiple transactions at prices ranging from $1.625 to $1.635 per share. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Gevo, Inc. insider Andrew Shafer reported selling 5,000 shares of Common Stock on 08/20/2025 at a weighted average price of $1.5833 per share under a 10b5-1 trading plan adopted November 22, 2024. After the reported sale, the filing shows Mr. Shafer beneficially owns 325,620 shares directly and an additional 9,806.92 shares indirectly through the issuer's 401(k) plan. The filing also discloses that between 07/21/2025 and 08/20/2025 he disposed of 3.77 shares under the 401(k) plan to cover administrative fees. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
FAQ
What is the current stock price of Gevo (GEVO)?
What is the market cap of Gevo (GEVO)?
